NASH

A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

Androgens and NAFLD Longitudinal Cohort Study

RE and Probiotics in MAFLD/NAFLD

Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)

A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients

Assessment of Fatty Liver With Thermo-acoustic Device

A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH

An Imaging-based Quantitative Biomarker Assay for NAFLD in Children

Evaluation of Risk of hEpatocellular Carcinoma

Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus

Digoxin In NASH (CODIN)

To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD

Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH